Wissenschaftliche Arbeiten

Doç. Dr. Kubilay Karaboyun

43 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Inflammatory and Nutritional Indices as Prognostic Markers in Locally Advanced Gastric Cancer Treated with Neoadjuvant FLOT: A Retrospective Multicenter Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15072574 PMID 41976874 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  2. Identifying high-risk groups for recurrence in endometrial cancer: The role of ESMO–ESGO–ESTRO risk classification

    Journal of Cancer Research and Therapeutics, 2026

    DOI 10.4103/jcrt.jcrt_1917_24 PMID 41910289 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  3. Management of Hypersensitivity in Oncology Practice: Risk Stratification, Phenotypic Markers, and Desensitization Protocols

    Research Square, 2026

    DOI 10.21203/rs.3.rs-9707882/v1 Frei zugänglicher VolltextQuelle: OpenAlex

  4. Survival Impact of Adjuvant Chemoradiotherapy in Resected Pancreatic Cancer

    Namık Kemal Tıp Dergisi, 2025

    DOI 10.4274/nkmj.galenos.2025.81994 Frei zugänglicher VolltextQuelle: OpenAlex

  5. Comprehensive analysis of the prognostic role of laboratory indices in advanced lung cancer patients

    Asia-Pacific Journal of Clinical Oncology, 2025

    DOI 10.1111/ajco.14092 PMID 38837742 8 Zitationen (Europe PMC) Quelle: ORCID

  6. The role of peripheral T lymphocyte subsets and PD-1 expression as a biomarker for neoadjuvant treatment response in breast cancer

    Medicine, 2025

    DOI 10.1097/md.0000000000044743 PMID 41029123 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  7. Prognostic Value of Estrogen Receptor Co-activator AIB1 in Metastatic Breast Cancer Patients Treated with a Combination of Ribociclib and Letrozole

    Bratislava Medical Journal, 2025

    DOI 10.1007/s44411-025-00237-y Frei zugänglicher VolltextQuelle: ORCID

  8. Expression of gamma-aminobutyric acid type A receptor subunit π and minichromosome maintenance-3 in breast cancer patients treated with neoadjuvant chemotherapy: a target molecule or a proliferation marker?

    Revista da Associação Médica Brasileira, 2025

    DOI 10.1590/1806-9282.20250507 PMID 41124552 Frei zugänglicher VolltextQuelle: ORCID

  9. Prognostic Role of Inflammatory and Nutritional Indices in NSCLC Patients Treated with Immune Checkpoint Inhibitors: Retrospective, Multicenter, Turkish Oncology Group Study of Overall and Elderly Populations

    Medicina, 2025

    DOI 10.3390/medicina61071160 PMID 40731790 7 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  10. Chronic kidney disease and denosumab in metastatic bone disease: A multicenter Turkish cohort study on severe hypocalcemia, skeletal events, and survival

    Journal of bone oncology, 2025

    DOI 10.1016/j.jbo.2025.100730 PMID 41399765 Frei zugänglicher VolltextQuelle: OpenAlex

  11. Kanser Hastalarının Başvurduğu Geleneksel ve Tamamlayıcı Tedaviler - Tıbbi Onkolog Gözü ile Bakış ve Onkolojik İlaçlarla Etkileşim

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2380 Frei zugänglicher VolltextQuelle: OpenAlex

  12. Geleneksel Çin Tıbbı

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2380.c13881 Quelle: ORCID

  13. Nanotechnology in oncology: a mini review

    Revista da Associação Médica Brasileira, 2024

    DOI 10.1590/1806-9282.20241347 PMID 39630738 Frei zugänglicher VolltextQuelle: ORCID

  14. Efficacy of Neoadjuvant Chemotherapy in Lobular and Rare Subtypes of Breast Cancer

    Journal of College of Physicians And Surgeons Pakistan, 2024

    DOI 10.29271/jcpsp.2024.01.37 PMID 38185958 5 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  15. Denosumab administration in breast, prostate and lung cancer with chronic kidney disease – a retrospective multicenter Turkish Oncology Group (TOG) study

    Research Square, 2024

    DOI 10.21203/rs.3.rs-5026529/v1 Frei zugänglicher VolltextQuelle: OpenAlex

  16. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

    BMC Cancer, 2023

    DOI 10.1186/s12885-023-10609-8 PMID 36765293 18 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  17. PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study

    Journal of Geriatric Oncology, 2023

    DOI 10.1016/j.jgo.2023.101604 PMID 37683369 10 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  18. Prognostic factors influencing regorafenib treatment outcomes in metastatic colorectal cancer

    Adıyaman Üniversitesi Sağlık Bilimleri Dergisi, 2023

    DOI 10.30569/adiyamansaglik.1355856 Frei zugänglicher VolltextQuelle: ORCID

  19. The Role of Interleukin-20 in Paclitaxel-Associated Peripheral Neuropathy in Non-Metastatic Breast Cancer Patients Receiving Chemotherapy

    Istanbul Medical Journal, 2023

    DOI 10.4274/imj.galenos.2023.59908 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  20. The prognostic role of neutrophil/lymphocyte ratio and monocyte/lymphocyte ratio in advanced stage gastric cancer patients receiving chemotherapy: a single center experience

    Interdisciplinary Medical Journal, 2023

    DOI 10.17944/interdiscip.1351892 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  21. Tamoxifen or aromatase inhibitors: which one is the culprit of urinary incontinence in premenopausal breast cancer patients receiving adjuvant hormone therapy?

    Supportive Care in Cancer, 2023

    DOI 10.1007/s00520-023-07791-7 PMID 37162602 4 Zitationen (Europe PMC) Quelle: ORCID

  22. Investigation of the Effect of Low-positive HER-2 on Neoadjuvant Chemotherapy Response in Hormone-positive Breast Cancer Patients

    Journal of Academic Research in Medicine, 2023

    DOI 10.4274/jarem.galenos.2023.30074 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  23. A logarithmic model for hormone receptor-positive and breast cancer patients treated with neoadjuvant chemotherapy

    Revista da Associação Médica Brasileira, 2023

    DOI 10.1590/1806-9282.20221255 PMID 36921198 Frei zugänglicher VolltextQuelle: ORCID

  24. Use of Complementary Therapy in Lung Cancer Patients Treated with Chemotherapy and its Effect on Survival: A Cross-sectional Study

    Medical Bulletin of Haseki, 2023

    DOI 10.4274/haseki.galenos.2023.8591 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  25. 90 day and 1-year mortality and renal outcomes of patients who started hemodialysis treatment for the first time

    Revista de Nefrologia, Dialisis Y Transplante, 2023

    Quelle: ORCID

  26. A New Mortality Prediction Model in Advanced Stage Cancer Patients Requiring Hospitalisation while Receiving Active Systemic Therapy

    Journal of College of Physicians and Surgeons Pakistan, 2023

    DOI 10.29271/jcpsp.2023.05.548 PMID 37190691 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  27. Evaluating inflammatory markers as predictive tools for advanced non-small cell lung cancer receiving nivolumab

    Annals of Clinical and Analytical Medicine, 2023

    DOI 10.4328/acam.21947 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  28. Stresli Yasam Olaylarının Meme Kanseri Gelişimdeki Rolü

    DergiPark (Istanbul University), 2023

    Frei zugänglicher VolltextQuelle: OpenAlex

  29. Fertility Desire and Protection Practices Among Turkish Young Breast Cancer Patients Treated with Chemotherapy

    Eurasian Journal of Medical Investigation, 2023

    DOI 10.14744/ejmi.2023.97379 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  30. Decrease in estimated glomerular filtration rates in non-small cell lung cancer patients treated with crizotinib

    Journal of Cancer Research and Therapeutics, 2022

    DOI 10.4103/jcrt.jcrt_1276_21 PMID 37313913 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  31. Nadir Tümörler

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.2239 1 Zitation (OpenAlex) Quelle: ORCID

  32. Efficacy and safety of trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer: a single center study

    Iberoamerican Journal of Medicine, 2022

    DOI 10.53986/ibjm.2022.0033 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  33. The influence of visual objects and music on anxiety levels of breast cancer patients scheduled to experience chemotherapy for the first time: a prospective randomized clinical study

    Supportive Care in Cancer, 2022

    DOI 10.1007/s00520-021-06778-6 PMID 35094139 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  34. Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer

    Journal of Geriatric Oncology, 2022

    DOI 10.1016/j.jgo.2022.03.004 PMID 35361561 18 Zitationen (Europe PMC) Quelle: ORCID

  35. Soluble B7H3 level in breast cancer and its relationship with clinicopathological variables and T-cell infiltration

    Wspolczesna Onkologia, 2022

    DOI 10.5114/wo.2022.113502 PMID 35506036 10 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  36. The diagnostic contribution of magnetic resonance imaging in the detection of axillary metastasis after neoadjuvant chemotherapy

    Neoplasma, 2022

    DOI 10.4149/neo_2022_220127n122 PMID 35471979 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  37. Immunogenicity and safety of the CoronaVac vaccine in patients undergoing treatment for breast and lung cancer

    Bratislavské lekárske listy/Bratislava medical journal, 2022

    DOI 10.4149/bll_2022_063 PMID 35576541 6 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  38. Comparison of three equations for estimating glomerular filtration rate as predictors of cisplatin-related acute kidney injury in lung cancer patients with normal renal function

    Journal of Cancer Research and Therapeutics, 2022

    DOI 10.4103/jcrt.jcrt_1405_22 PMID 38554312 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  39. Paratiroid Tümörleri

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.2239.c17292 Quelle: OpenAlex

  40. Kutanöz Adneksiyal Tümörler

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.2239.c17337 Quelle: OpenAlex

  41. Effects of COVID-19 Pandemic on Diagnosis-treatment Process in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

    Namık Kemal Tıp Dergisi, 2021

    DOI 10.4274/nkmj.galenos.2021.69775 Frei zugänglicher VolltextQuelle: ORCID

  42. EVALUATION OF DEMOGRAPHIC, LABORATORY DATA AND SURVIVAL OF THE PATIENTS WHO UNDERWENT HEMODIALYSIS FOR THE FIRST TIME

    Nephrology Dialysis Transplantation, 2019

    Quelle: ORCID

  43. SP659EVALUATION OF DEMOGRAPHIC, LABORATORY DATA AND SURVIVAL OF THE PATIENTS WHO UNDERWENT HEMODIALYSIS FOR THE FIRST TIME

    Nephrology Dialysis Transplantation, 2019

    DOI 10.1093/ndt/gfz103.sp659 Frei zugänglicher VolltextQuelle: OpenAlex